PAYO vs. RTO, CART, ALLE, MEDP, ULS, WPP, GLOB, HQY, STN, and BILI
Should you be buying Payoneer Global stock or one of its competitors? The main competitors of Payoneer Global include Rentokil Initial (RTO), Maplebear (CART), Allegion (ALLE), Medpace (MEDP), UL Solutions (ULS), WPP (WPP), Globant (GLOB), HealthEquity (HQY), Stantec (STN), and Bilibili (BILI). These companies are all part of the "business services" industry.
Payoneer Global vs.
Payoneer Global (NASDAQ:PAYO) and Rentokil Initial (NYSE:RTO) are both business services companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, dividends, valuation, community ranking and profitability.
In the previous week, Rentokil Initial had 27 more articles in the media than Payoneer Global. MarketBeat recorded 28 mentions for Rentokil Initial and 1 mentions for Payoneer Global. Payoneer Global's average media sentiment score of 0.42 beat Rentokil Initial's score of 0.02 indicating that Payoneer Global is being referred to more favorably in the media.
Rentokil Initial has higher revenue and earnings than Payoneer Global.
Payoneer Global has a net margin of 13.82% compared to Rentokil Initial's net margin of 0.00%. Payoneer Global's return on equity of 17.78% beat Rentokil Initial's return on equity.
Payoneer Global presently has a consensus target price of $11.86, indicating a potential upside of 14.67%. Rentokil Initial has a consensus target price of $29.00, indicating a potential upside of 22.49%. Given Rentokil Initial's higher probable upside, analysts clearly believe Rentokil Initial is more favorable than Payoneer Global.
Payoneer Global has a beta of 0.92, meaning that its stock price is 8% less volatile than the S&P 500. Comparatively, Rentokil Initial has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500.
Payoneer Global received 49 more outperform votes than Rentokil Initial when rated by MarketBeat users. Likewise, 72.60% of users gave Payoneer Global an outperform vote while only 30.77% of users gave Rentokil Initial an outperform vote.
82.2% of Payoneer Global shares are held by institutional investors. Comparatively, 9.9% of Rentokil Initial shares are held by institutional investors. 5.6% of Payoneer Global shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Summary
Payoneer Global beats Rentokil Initial on 11 of the 17 factors compared between the two stocks.
Get Payoneer Global News Delivered to You Automatically
Sign up to receive the latest news and ratings for PAYO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Payoneer Global Competitors List
Related Companies and Tools
This page (NASDAQ:PAYO) was last updated on 1/21/2025 by MarketBeat.com Staff